The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
The 12 Years A Slave director is filming an artwork as a 'lasting memorial' to the Grenfell Tower fire tragedy.
A frosty start to Sunday for many with slow-clearing mist and fog in the southeast.
Diane Abbott said Labour's position is to have 'less bureaucracy' in order to allow easy movement for EU migrants.